Progesterone and hCG in expectant management success in tubal ectopic pregnancy: retrospective single-centre cohort study
Rattachement africain : gb. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Abstract Background Early access to pregnancy assessment units now detects many tubal ectopic pregnancies (TEP) at a stage when they could resolve spontaneously, creating a management dilemma. Methods We performed a hypothesis-generating exploratory analysis in a retrospective study to assess whether serum progesterone (P4) levels in women with TEP are associated with management outcome. Results Ninety-one cases of TEP managed in a single centre over three years were analysed. Receiver operating characteristic (ROC) curve analysis was used to explore serum levels of progesterone (P4), first human chorionic gonadotropin (hCG) and peak hCG (alone and in combination) in relation with successful completion of expectant management. Decision-tree analysis using first hCG and P4 was additionally performed to explore clinical sequential risk stratification. 23% (n=21) successfully completed expectant management. P4 concentrations in the expectant management group (median 3 nmol/L, IQR 2.00–8.50) were significantly lower than in those requiring surgical or medical management (median 17 nmol/L, IQR 5.75– 29.25; p=0.0002). Area under the ROC curve (AUC) values for P4, log10 first hCG, log10 peak hCG and P4 with log10 first hCG were 0.766, 0.814, 0.811 and 0.835, respectively, for predicting successful expectant management. However, hCG was not significantly outperformed. Nonetheless, Youden optimised thresholds for hCG and P4 are reported, alongside decision-tree analysis that identified sequential first hCG and P4 thresholds associated with successful expectant management. Conclusion Lower P4 levels are associated with successful expectant management of TEP but they do not outperform hCG either alone or as an adjunctive marker. Lay summary Early pregnancy scans now identify many small, symptom-free fallopian tube pregnancies; human chorionic gonadotrophin (hCG) is a pregnancy hormone that can predict if these pregnancies will resolve naturally but it has its limitations. This study looked at 91 women with a fallopian tube pregnancy. It compared another important hormone called progesterone to see if, when used with hCG, its levels are associated with natural resolution. This study found that hCG was the most useful test, and progesterone did not provide any additional benefit.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Progesterone and hCG in expectant management success in tubal ectopic pregnancy: retrospective single-centre cohort study
- Date Crossref
- 07/08/2026
- Éditeur
- openRxiv
- Type
- posted-content
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Chelsea and Westminster Hospital Department of Obstetrics and Gynaecology pays non établi dans la noticeÉtablissement de santé
-
Imperial College London Department of Metabolism pays non établi dans la noticeUniversité ou école supérieure
Department of Obstetrics and Gynaecology — Chelsea and Westminster Hospital et Department of Metabolism — Imperial College London.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.